Preclinical AML studies showed palbociclib plus venetoclax produced stronger, more durable anti‑leukemia activity than venetoclax alone and may overcome resistance.
Morning Overview on MSN
Doctors spot microplastics in arteries tied to heart attacks, strokes
Doctors are no longer just warning that plastic is everywhere in the environment. They are now literally finding tiny ...
Applicants are not supposed to use AI to write college essays. But colleges are using AI to help assess applications. At ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback